Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Selloff or Market Correction? Either Way, Here's What to Do Next
See Overvalued Stocks
Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur (0P00000ITG)
Add to/Remove from Watchlist
Add to Watchlist
42.310
+0.100
+0.24%
20/12 - Delayed Data. Currency in EUR
- Morningstar Rating:
- Total Assets: 3.79B
Janus Henderson Capital Funds plc - Global Life Sc
42.310
+0.100
+0.24%
- Overview
- Profile
- Historical Data
- Holdings
Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur Overview
On this page you'll find an in-depth profile of Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur. Learn about the key management, total assets, investment strategy and contact information of 0P00000ITG among other information.
Investment Strategy
The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.
Contact Information
Address
201 Bishopsgate
London,London EC2M 3AE
United Kingdom
London,London EC2M 3AE
United Kingdom
Phone
8002270486
Top Executives
| Name | Title | Since | Until |
|---|---|---|---|
| Daniel Lyons | Portfolio Manager | 2023 | Now |
| Biography | "Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors. Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience." | ||
| Andy Acker | Portfolio Manager | 2007 | Now |
| Biography | "Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience." | ||
| Ethan Lovell | Portfolio Manager | 2015 | 2022 |
| Biography | Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. | ||
| Thomas R. Malley | Portfolio Manager | 2000 | 2007 |
| Biography | Malley joined Janus Capital Corporation in 1991 and currently serves as a portfolio manager. Malley holds the Chartered Financial Analyst designation. | ||
Write your thoughts about Janus Henderson Capital Funds Plc - Global Life Sciences Fund Class A2 Heur
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review